Call for Proposals
Call for Proposals
Proposal Submission is now Open!
The International Neuromodulation Society invites members to submit proposals for plenary and breakout lectures, and other presentations for its 17th World Congress, which will take place in Lisbon, Portugal on 9-14 May 2026.
The Congress program, “Neuromodulation: Bridging Minds, Machines, and Medicine” will be organized in accordance with EACCME and ACCME guidelines and will further the INS’s educational mission to promote improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational content focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners’ knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.
We invite you to submit proposals, each containing up to 5 presentations on a single topic. If you wish to submit presentations on different topics, please submit separate proposals for each.
To streamline your submission process, we recommend keeping your proposals in draft status until you have finalized all the presentations under that topic. This will allow you to add additional presentations without the need to submit a new proposal.
Remember to click Submit in the Proposal system before the deadline: 14 May 2025.
The Scientific Program Chairs and Biennial Congress Scientific Committee are particularly interested in proposals featuring basic science, mechanisms of action, and biomedical engineering, and will consider the full breadth of neuromodulation-related topics as follows:
- Neuromodulation Basic Science / Basic Neuroscience / Animal Models
– Invasive Neuromodulation
– Non-Invasive Neuromodulation - Neuromodulation Neuroengineering
- Neuroprosthetics / Brain Computer Interface (BCI)
- Socioeconomics of Neuromodulation
- AI in Neuromodulation
- Big Data / Registries / Real World Data
- Neuromodulation Biomarkers and Outcomes
- Patient Advocacy / Ethics of Neuromodulation
- Global Health and Access to Neuromodulation
- Neurorehabilitation with Neuromodulation
- Invasive Brain Stimulation
– Brain: Invasive Stimulation (DBS) Movement Disorders and Spasticity
– Brain: Invasive Stimulation (DBS) Psychiatric and Cognitive Disorders
– Brain: Invasive Stimulation for Rehabilitation
– Brain: Invasive Stimulation for Pain
– Brain: Invasive Stimulation for Epilepsy
- Non-Invasive Brain Stimulation (NIBS)
– Brain: Non-Invasive Stimulation Technologic Advances / Treatment Protocols
– Brain: Non-Invasive Stimulation for Psychiatric and Cognitive Disorders
– Brain: Non-Invasive Stimulation (DBS) Movement Disorders and Spasticity
– Brain: Non-Invasive Stimulation for Rehabilitation
– Brain: Non-Invasive Stimulation for Pain
– Low Intensity Focused Ultrasound (LIFU) - Spinal Cord Stimulation (SCS) / Peripheral Nerve Stimulation (PNS)
– Spinal Cord Stimulation for Pain
– Spinal Cord Stimulation for Rehabilitation / Gait and Motor Dysfunction
– Spinal Cord / Peripheral Nerve Stimulation for Cardiovascular Diseases
– Peripheral Nerve Stimulation for Headache
– Peripheral Nerve Stimulation for Pain
– Peripheral Nerve Stimulation for Systemic Disorders
– Peripheral Nerve Stimulation for Rehabilitation / Functional Restoration - Vagus Nerve Stimulation (VNS)
– Vagus Nerve Stimulation for Epilepsy
– Vagus Nerve Stimulation for Systemic Disorders
– Vagus Nerve Stimulation for Neuropsychiatric and Cognitive Disorders - Intrathecal Drug Delivery (IDD)
– Intrathecal Drug Delivery for Non-Cancer Pain
– Intrathecal Drug Delivery for Cancer Pain
– Intrathecal Drug Delivery for Spasticity - Pulsed Radiofrequency for Pain (PRF)
- Gastrointestinal Neuromodulation
- Genitourinary Neuromodulation for GU disorders and Pelvic Pain
- Gene Therapy in Neuromodulation
- Other*
*If none of the above categories applies to your topic of interest, please submit under “other”.
The submission deadline is: 14 May 2025
Note: This is not a call for abstracts. We shall inform you once the abstract submission system has opened.
For any questions, please contact ins_abstracts@kenes.com